Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K080192
    Date Cleared
    2008-04-03

    (69 days)

    Product Code
    Regulation Number
    870.2300
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    HYPERVISOR VI CENTRAL MONITORING SYSTEM (INCLUDING TMS)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CMS network transfers information between HYPERVISOR VI Central Monitoring System and other networked devices. It also allows information transfer between several CMS. Network connections consist of hardwired network cables and/or WLAN connections. CMS can be used for remote monitor management, storing, printing, reviewing or processing of information from networked devices, and it is operated by medical personnel in hospitals or medical institutions.

    Telemetry Monitoring System is a sub-system of CMS, intended to obtain ECG and SpO2 physiological information from adult and pediatric patients, and send it to CMS via WMTS frequency within a defined coverage area.

    Device Description

    Central Monitoring System network is a kind of medical information system, which consists of different networked devices (which have separate 510(k) clearance). Hypervisor VI Central Monitoring System (CMS) is the primary maintainer of communication between other networked devices. It can store, print, review or process information from networked devices. It can also realize remote monitor management function to free doctors from clinical monitoring work and conduct centralized monitoring management.

    In this submission, CMS adds the function of supporting communication with Telemetry Monitoring System. Besides this, CMS is improved to include some new functions, such as, add the function of ViewOtherBed and add the function of real-time print.

    By using radiofrequency signal, TMS is intended to monitor Electrocardiogram (ECG), Heart Rate (HR), Arrhythmia Detection, ST Segment Analysis, Saturation of Pulse Oxygen (SpO2) and Pulse Rate (PR) for adult and pediatric patients. Physical signals are collected by sensors and wirelessly transmitted by transmitters in WMTS band, receivers get the signals and forward to CMS for processing, displaying, storing, printing, etc. It can be used within a defined coverage area in hospitals or medical institutions.

    CMS is based on the PC platform, and the PC can be configured by users according to the requirements on the operator's manual.

    AI/ML Overview

    The provided text describes a 510(k) summary for the HYPERVISOR VI Central Monitoring System (including TMS) but does not contain detailed information about acceptance criteria or specific study results that prove the device meets such criteria.

    Here's an analysis based on the available information regarding your requested points:


    1. Table of Acceptance Criteria and Reported Device Performance

    Not available in the provided text. The document states:
    "Laboratory testing has been conducted to validate and verify that the CMS (including TMS) meet all design specifications. Results of these tests demonstrate compliance to the requirements of all applied standards."
    However, it does not specify what those design specifications or their acceptance criteria were, nor does it present the actual performance results in a table or any other format.

    2. Sample Size Used for the Test Set and Data Provenance

    Not available in the provided text. There is no mention of a test set, its sample size, or the provenance of any data used for testing.

    3. Number of Experts Used to Establish Ground Truth and Their Qualifications

    Not available in the provided text. There is no information about expert involvement in establishing ground truth.

    4. Adjudication Method for the Test Set

    Not available in the provided text. No test set details, let alone an adjudication method, are mentioned.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    Not applicable/Not available. The document describes a Central Monitoring System and a Telemetry Monitoring System, which are devices primarily focused on data communication, storage, and display of physiological parameters (ECG, HR, SpO2, PR). These are not AI-assisted interpretative or diagnostic tools for which an MRMC comparative effectiveness study would typically be performed to assess human reader improvement with AI assistance. The text does not mention any AI components or human-in-the-loop assistance features.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    Not available/Not applicable in the context of an "algorithm only" study as it is understood for diagnostic AI. The device is a monitoring system. The closest equivalent would be performance testing of its internal algorithms for parameter measurement (e.g., arrhythmia detection, ST segment analysis) and communication, but specific details of such studies are not provided beyond the general statement of "Laboratory testing."

    7. Type of Ground Truth Used

    Not available in the provided text. Given that the device is a monitoring system, ground truth would likely refer to validated reference measurements for ECG, SpO2, heart rate, and arrhythmia detection, but the document does not specify how this was established or what type of ground truth was used.

    8. Sample Size for the Training Set

    Not applicable/Not available. This device is a monitoring and communication system, not a device that typically "learns" from a training set in the way AI/ML algorithms do. Therefore, a training set in that sense is not relevant and not mentioned.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable/Not available, as there is no mention of a training set.


    Summary of what is available regarding testing:

    The 510(k) summary broadly states:

    • "Laboratory testing has been conducted to validate and verify that the CMS (including TMS) meet all design specifications."
    • "Results of these tests demonstrate compliance to the requirements of all applied standards."

    However, it does not provide:

    • Specific acceptance criteria (e.g., sensitivity, specificity, accuracy thresholds).
    • Detailed study protocols or methodologies.
    • Actual performance values (e.g., "The device achieved X sensitivity and Y specificity").
    • Information on data sets used (sample size, provenance).
    • Details about expert review or ground truth establishment.

    The focus of this 510(k) appears to be primarily on establishing substantial equivalence to predicate devices based on technological characteristics and software modifications, rather than presenting detailed clinical performance data from a specific study against predefined acceptance criteria for a diagnostic/interpretive algorithm.

    Ask a Question

    Ask a specific question about this device

    K Number
    K062194
    Date Cleared
    2007-04-11

    (254 days)

    Product Code
    Regulation Number
    870.1025
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    HYPERVISOR VI CENTRAL MONITORING SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Central Monitoring System is intended to conduct centralized monitoring of adult, pediatric and neonatal vital sign information from multiple monitors in hospitals or medical institutions, the monitoring parameters include ECG, NIBP, SpO2, PR, RESP, IBP, TEMP, CO2 and AG. It is not intended for home use.

    Device Description

    Central Monitoring System is a kind of medical information system widely applied in clinical monitoring, whose operation requires specific hardware environment such as a PC platform, the PC and Operation System is dedicated. Depending on the specific hardware platform, the Central Monitor System constitutes a monitoring network system together with software, the Operation System and work together with bedside monitors. It can collect, and export the monitoring information of the patient transferred via network from the bedside monitor. It can also display and export the integrated information from bedside monitors so as to free-up doctors from clinical monitoring work and create centralized monitoring management.

    The HYPERVISOR VI Central Monitoring System is a medical information system. This System includes a high-performance PC hardware system, the application software and Windows operation system (Windows XP). Through applying Mindray specified protocol, the Central Monitoring System obtains physiological information from cleared bedside monitors manufactured by Mindray, includes: PM-8000 Express, PM-9000 Express and VS-800.

    The Central Monitoring System can maximally support the simultaneous networking of 32 bedside monitors. Also, TCP/IP protocol is applied to ensure reliable transmission of network data.

    The Central Monitoring System offers centralized display of physiological information of many patients who are currently monitored simultaneously. The software can support two displays simultaneously, and can display information from up to 16 bedside monitors on a display and 32 bedside monitors on two displays simultaneously. And if any of the bedside monitors gives off alarm, prompt information will be immediately displayed by means of audible /words for medical personnel's attention.

    The physiological waveforms displayed on the central monitoring system include to: ECG waveforms, RESP waveforms, CO2 waveforms, PLETH waveforms, IBP waveforms, and AG waveforms. The physiological parameters displayed on the central monitoring system include: HR, RR, SpO2, PR, SYS, DIA, MEAN, TEMP, CO2, AwRR.

    Central Monitoring System makes an announcement for the physiological parameters based on the bedside monitor. The software also performs notification directly for alarms from the bedside monitor and triggers technical alarms for the error and failure of itself. Moreover database technology is applied to store these alarm events for the convenience of doctor's review and analysis.

    AI/ML Overview

    The provided text describes the HYPERVISOR VI Central Monitoring System and aims to demonstrate its substantial equivalence to a legally marketed predicate device. However, it does not contain the specific details required to fully address all parts of your request regarding acceptance criteria and a detailed study.

    Here's what can be extracted and what information is missing:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document states that the conclusion drawn from testing and validation demonstrates the device is "as safe, as effective, and performs as well as the legally marketed predicate device, the M3150 Information Center (K#011093, by Agilent Co., Ltd)."

    This implies that the acceptance criterion was substantial equivalence to the predicate device. However, the document does not specify quantifiable performance metrics or a detailed table of acceptance criteria used in the testing and validation, nor does it present specific performance data for the HYPERVISOR VI Central Monitoring System.

    Missing Information: Specific numerical acceptance criteria (e.g., accuracy percentages, latency thresholds, alarm reliability rates) and the corresponding reported performance values from the study are not provided in this summary.

    2. Sample size used for the test set and the data provenance:

    Missing Information: The document does not provide any information regarding the sample size used for the test set or the data provenance (e.g., country of origin, retrospective/prospective nature).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    Missing Information: There is no mention of experts being used to establish a ground truth for a test set, nor their number or qualifications. This type of device (a central monitoring system displaying vital signs) would likely rely on direct comparison of displayed values to those from source monitors rather than expert interpretation for ground truth.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    Missing Information: No information about an adjudication method is provided.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    Not Applicable/Missing Information: This device is a central monitoring system for displaying vital signs, not an AI-assisted diagnostic tool for human readers. Therefore, an MRMC comparative effectiveness study would not be relevant in this context, and no such study is mentioned.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    The device described is a "Central Monitoring System" which "collects, and exports the monitoring information of the patient transferred via network from the bedside monitor." It "offers centralized display of physiological information" and "makes an announcement for the physiological parameters based on the bedside monitor." This implies it operates in a standalone (algorithm only) capacity in terms of data collection, processing, and display, without a human-in-the-loop directly influencing its core function of data presentation from bedside monitors.

    The "study" referenced in the "Conclusion" section ("The conclusions drawn from testing and validation...") would therefore refer to the performance of the system itself in accurately collecting, transmitting, displaying, and alarming based on the data received from the bedside monitors.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    Given the nature of the device as a central monitoring system for vital signs, the ground truth would most likely be established by direct comparison to the data generated by the source bedside monitors themselves. For example, comparing the heart rate displayed on the central monitor to the heart rate transmitted by the bedside monitor.

    Missing Information: The document does not explicitly state the type of ground truth used.

    8. The sample size for the training set:

    Not Applicable/Missing Information: This device is a data display and management system, not a machine learning model that requires a "training set" in the traditional sense. It processes and displays existing physiological data.

    9. How the ground truth for the training set was established:

    Not Applicable/Missing Information: As above, the concept of a "training set" and its associated ground truth establishment is not relevant for this type of device according to the provided text.


    Summary of available information regarding the "study" findings:

    • Study Goal: To demonstrate substantial equivalence of the HYPERVISOR VI Central Monitoring System to the Agilent Technologies Information Center (AIC) Software (K011093).
    • Methodology Hint: "Testing and validation" were performed.
    • Outcome/Conclusion: The device is "as safe, as effective, and performs as well as the legally marketed predicate device."
    • Key Differences noted (suggesting aspects compared):
      • M3150 (predicate) offers ST segment and arrhythmia analysis; HYPERVISOR VI does not.
      • M3150 offers Telemetry and wireless monitoring; HYPERVISOR VI does not.
      • PC requirements differ (OS, CPU).
      • Maximum number of connecting bedside monitors differs (HYPERVISOR VI: 32; M3150: 16).
    • Missing Details: Specific tests conducted, test protocols, numerical results, statistical analyses, or the detailed parameters measured during the "testing and validation" are not included in this 510(k) summary. The summary focuses on comparing technical specifications and overall intended use rather than detailed performance study results.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1